|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 329.81 USD | -0.24% |
|
-0.34% | -10.60% |
| 12-05 | Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence | CI |
| 12-04 | Monks Investment notes "deliberate" AI approach in strong first half | AN |
| Capitalization | 73.3B 62.98B 59.08B 55.05B 101B 6,586B 110B 685B 266B 3,122B 275B 269B 11,501B | P/E ratio 2025 * |
13x | P/E ratio 2026 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise value | 96.03B 82.51B 77.4B 72.12B 133B 8,628B 144B 898B 349B 4,090B 360B 353B 15,068B | EV / Sales 2025 * |
0.49x | EV / Sales 2026 * | 0.47x |
| Free-Float |
99.81% | Yield 2025 * |
2.03% | Yield 2026 * | 2.13% |
Last Transcript: Elevance Health, Inc.
| 1 day | -0.24% | ||
| 1 week | -0.34% | ||
| Current month | -2.50% | ||
| 1 month | +3.79% | ||
| 3 months | +4.67% | ||
| 6 months | -15.35% | ||
| Current year | -10.60% |
| 1 week | 323.04 |  | 336.45 |
| 1 month | 303.6 | | 341.89 |
| Current year | 273.71 | | 458.75 |
| 1 year | 273.71 | | 458.75 |
| 3 years | 273.71 | | 567.26 |
| 5 years | 273.71 | | 567.26 |
| 10 years | 114.85 | | 567.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 64 | 19/11/2017 |
Mark Kaye
DFI | Director of Finance/CFO | 46 | 31/10/2023 |
Dustin Wilcox
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
CHM | Chairman | 69 | - |
Robert Dixon
BRD | Director/Board Member | 69 | 30/06/2011 |
Lewis Hay
BRD | Director/Board Member | 69 | 30/06/2013 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.22% | 26 M€ | +11.19% | - |
| 2.07% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.24% | -0.34% | -16.64% | -37.17% | 73.3B | |
| -0.01% | -0.29% | -42.28% | -39.99% | 293B | |
| -0.31% | -4.16% | -17.68% | -20.90% | 70.18B | |
| -2.34% | +3.48% | -12.52% | -53.06% | 30.12B | |
| +0.53% | -1.88% | -34.89% | -55.85% | 18.72B | |
| +0.88% | +7.47% | -48.82% | -54.01% | 8.06B | |
| -0.77% | +0.63% | +68.07% | +65.89% | 3.84B | |
| +0.08% | -0.92% | +56.06% | -21.27% | 2.13B | |
| +1.17% | +4.02% | -21.52% | +129.20% | 1.34B | |
| +3.82% | +2.60% | -20.76% | - | 404M | |
| Average | +0.27% | +1.28% | -9.10% | -9.68% | 50.12B | |
| Weighted average by Cap. | -0.23% | -0.53% | -31.79% | -37.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 198B 170B 160B 149B 274B 17,784B 298B 1,850B 719B 8,429B 743B 727B 31,058B | 205B 176B 165B 154B 284B 18,421B 308B 1,916B 745B 8,731B 769B 753B 32,169B |
| Net income | 5.7B 4.89B 4.59B 4.28B 7.88B 512B 8.56B 53.25B 20.69B 243B 21.38B 20.92B 894B | 5.39B 4.63B 4.35B 4.05B 7.46B 485B 8.11B 50.41B 19.59B 230B 20.24B 19.81B 846B |
| Net Debt | 22.73B 19.53B 18.32B 17.07B 31.44B 2,042B 34.17B 212B 82.58B 968B 85.3B 83.49B 3,567B | 23.08B 19.83B 18.61B 17.34B 31.93B 2,074B 34.7B 216B 83.86B 983B 86.62B 84.79B 3,622B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 329.81 $ | -0.24% | 1,296,178 |
| 08/12/25 | 330.61 $ | -0.04% | 1,765,482 |
| 05/12/25 | 330.75 $ | -0.82% | 1,324,214 |
| 04/12/25 | 333.49 $ | +0.83% | 2,357,333 |
| 03/12/25 | 330.75 $ | -0.05% | 1,691,857 |
Delayed Quote Nyse, December 09, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition